Sigma-Aldrich competitors

Zippia score 4.9

Sigma-Aldrich main competitors are Merck, Regeneron, and Watson Pharma Pvt Ltd.

Competitor Summary. See how Sigma-Aldrich compares to its main competitors:

Merck has the most employees (74,000).
Employees at Merck earn more than most of the competitors, with an average yearly salary of $90,328.
The oldest company is Fougera Pharmaceuticals, founded in 1849.

Work at Sigma-Aldrich?

Share your experience

Sigma-Aldrich vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Sigma-Aldrich	1951	4.9	Saint Louis, MO	2	$2.8B	9,600
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Tris Pharma	2000	4.2	Monmouth Junction, NJ	1	$102.0M	200
Sun Pharmaceutical Industries Inc.	1984	4.6	Cranbury, NJ	3	$4.2B	32,000
Mallinckrodt	1867	4.8	Hazelwood, MO	5	$1.0B	3,400
Watson Pharma Pvt Ltd	1984	4.9	Parsippany-Troy Hills, NJ	1	$5.9B	21,600
Mylan	1961	4.8	Canonsburg, PA	2	$11.5B	35,000
Perrigo	1887	4.9	Greenville, SC	3	$4.4B	10,220
Pharmaceutics International	1994	4.5	Huntingtown, MD	2	$367.8M	1,000
Qualitest Pharmaceuticals	1983	4.1	Huntsville, AL	1	$230.0M	7,500
Par Pharmaceutical Inc	2003	4.9	Spring Valley, NY	4	$260.0M	400
ALZA Corporation	1968	4.3	Vacaville, CA	1	$200.0M	10,000
Quidel	1979	4.7	San Diego, CA	3	$1.7B	1,500
West-Ward Pharmaceuticals	1946	4.9	Eatontown, NJ	7	$150.0M	249
Paddock Laboratories	1977	4.3	Minneapolis, MN	1	$100.5M	51
TISHCON	1977	3.7	Westbury, NY	2	$25.9M	200
EMD Millipore	1954	4.8	Billerica, MA	1	$7.2B	6,100
PerSeptive Biosystems, Inc	1989	4.0	Framingham, MA	1	-	605
Fougera Pharmaceuticals	1849	4.1	Melville, NY	1	-	750
Tolmar Inc	2009	4.7	Fort Collins, CO	2	$120.0M	388

Rate how well Sigma-Aldrich differentiates itself from its competitors.

Sigma-Aldrich salaries vs competitors

Among Sigma-Aldrich competitors, employees at Merck earn the most with an average yearly salary of $90,328.

Compare Sigma-Aldrich salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Sigma-Aldrich	$69,774	$33.55	-
Merck	$90,328	$43.43	-
Regeneron	$85,589	$41.15	-
Tris Pharma	$67,691	$32.54	-
Sun Pharmaceutical Industries Inc.	$72,061	$34.64	-
Mallinckrodt	$61,563	$29.60	-

Compare Sigma-Aldrich job title salaries vs competitors

Company	Highest salary	Hourly salary
Sigma-Aldrich	$118,635	$57.04
Quidel	$139,791	$67.21
Merck	$128,962	$62.00
Regeneron	$127,637	$61.36
Watson Pharma Pvt Ltd	$125,000	$60.10
Mallinckrodt	$116,864	$56.18
Sun Pharmaceutical Industries Inc.	$113,795	$54.71
Tris Pharma	$112,985	$54.32
TISHCON	$111,371	$53.54
PerSeptive Biosystems, Inc	$111,036	$53.38
Mylan	$110,959	$53.35
Paddock Laboratories	$110,873	$53.30
ALZA Corporation	$110,477	$53.11
EMD Millipore	$110,034	$52.90
Qualitest Pharmaceuticals	$109,907	$52.84
Pharmaceutics International	$109,710	$52.75
Par Pharmaceutical Inc	$109,451	$52.62
Perrigo	$109,393	$52.59
Fougera Pharmaceuticals	$109,041	$52.42
West-Ward Pharmaceuticals	$108,348	$52.09

Do you work at Sigma-Aldrich?

Does Sigma-Aldrich effectively differentiate itself from competitors?

Sigma-Aldrich jobs

Sigma-Aldrich demographics vs competitors

Compare gender at Sigma-Aldrich vs competitors

Job title	Male	Female
Merck	54%	46%
Regeneron	54%	46%
EMD Millipore	57%	43%
Mylan	57%	43%
Quidel	58%	42%
Sigma-Aldrich	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Sigma-Aldrich vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Merck	56%	16%	10%	14%	4%	9.8
Quidel	50%	24%	8%	14%	5%	9.8
Regeneron	54%	15%	10%	17%	4%	9.8
EMD Millipore	62%	14%	6%	15%	3%	9.8
Mylan	62%	18%	7%	10%	3%	9.3
Sun Pharmaceutical Industries Inc.	43%	10%	9%	32%	6%	9.8

Sigma-Aldrich and similar companies CEOs

CEOBio

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Douglas C. Bryant

Quidel

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Mr. John Golubieski

Fougera Pharmaceuticals

Mr. John Golubieski is a President and Chief Executive Officer at Fougera Pharmaceuticals Inc and is based in United States.

Mark Trudeau

Mallinckrodt

Heather Bresch

Mylan

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Abhay Gandhi

Sun Pharmaceutical Industries Inc.

Anil D'Souza

Tolmar Inc

Anil D'souza is a Chief Executive Officer at TOLMAR and is based in Lincolnshire, Illinois. He has worked as President, Japan & Emerging Markets at HOSPIRA INC; First Lieutenant at Marine Corps Recruiting; and Client Manager at INTERNATIONAL BUSINESS MACHINES CORP. Anil attended Tuck School of Business at Dartmouth between 1998 and 2000, University of Chicago Committee on International Relations between 1989 and 1991, and University of Chicago between 1987 and 1991.

John Fowler

Pharmaceutics International

Murray S. Kessler

Perrigo

Yogesh Patel

TISHCON